The board of directors of Aoyuan Healthy Life Group Company Limited hereby announced that Mr. Tao Yu has tendered his resignation and will cease to act as the executive Director with effect from 25 November 2021 due to his other work commitments. Mr. Tao will be redesignated as the vice president of the Group following his resignation as an executive Director. Following Mr. Tao's resignation, the Board announced that Mr. Cheng Siu Fai has been appointed as an executive Director with effect from 25 November 2021 and is responsible for overseeing the strategy formulation and management of the corporate finance, capital operation and management and business acquisitions of the Group. Mr. Cheng has obtained a bachelor's degree in accounting and economics from Curtin University in Australia in 2009. Mr. Cheng possesses extensive working experience in several aspects, such as financial management, corporate finance, capital market and investor relations. From April 2020 to November 2020, Mr. Cheng has served as the vice president of the Group and the Chief Financial Officer and was in charge of the relevant sectors of the Group, such as financial, capital management, corporate finance, capital market operations and investor relations. Prior to joining the Group, he successively served as the finance manager, general finance manager, financial controller of China Aoyuan Group Limited, the controlling shareholder of the Company and the shares of which are listed on the Main Board of the Stock Exchange (Stock Code: 3883) ("China Aoyuan") and vice president of international investment group of China Aoyuan from July 2007 to April 2020. Mr. Cheng has been re-appointed as vice president of international investment group of China Aoyuan from August 2021.